|
1.Subas M. Sakya, Kristin M. Lundy DeMello, Martha L. Minich et al., 5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog, Bioorg. Med. Chem. Lett., 16, 288-292 (2006)
2.Tanitame A., Oyamada Y., Ofuji K., Fujimoto M., Iwai N., Hiyama Y., Suzuki K., Ito H., Terauchi H., Kawasaki M., Nagai K., Wachi M., Yamagishi J., Synthesis and Antibacterial Activity of a Novel Series of Potent DNA Gyrase Inhibitors. Pyrazole Derivatives, J. Med. Chem., 47, 3693-3696 (2004)
3.Bhat B.A., Dhar K.L., Puri S.C., Saxena A.K., Shanmugavel M., Qazi G.N., Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents, Bioorg. Med. Chem. Lett., 15, 3177- 3180 (2005)
4.Adnan A. Bekhit, Hamdy M. Abdel-Rahman, Aida A. Guemei, Synthesis and Biological Evaluation of Some Hydroxypyrazole Derivatives as Antiinflammatory – Antimicrobial Agents, Arch. Pharm., 339, 81-87 (2006)
5.Michael J. Genin, Carolyn Biles, Barb J. Keiser et al., Novel 1,5-Diphenyl- pyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine- Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives, J. Med. Chem., 43, 1034-1040 (2000)
6.Chimenti F., Maccioni E., Secci D., Bolasco A., Chimenti P. et al., Synthesis, molcular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl- 4,5-dihydro-(1H)-pyrazole derivatives, J. Med. Chem., 48, 7113-7122 (2005)
7.Selwood D.L., Brummell D.G., Budworth J., Burtin G.E. et al., Synthesis and Biological Evaluation of Novel Pyrazoles and Indazoles as Activators of the Nitric Oxide Receptor, Soluble Guanylate Cyclase, J. Med. Chem., 44(1), 78-93 (2001)
8.Gisele A. Nishiguchi, Alice L. Rodriguez and John A. Katzenellenbogen, Diaryl-Dialkyl-Substituted Pyrazoles: Regioselective Synthesis and Binding Affinity for the Estrogen Receptor, Bioorg. Med. Chem. Lett.,12, 947–950 (2002)
9.Hai-Bing Zhou, Kathryn E. Carlson, Fabio Stossi, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Analogs of methyl-piperidinopyrazole (MPP): Antiestrogens with estrogen receptor a selective activity, Bioorg. Med. Chem. Lett. (2008)
10.Shashikanth Ponnala, Devi Prasad Sahu, Iodine-Mediated Synthesis of 2-Arylbenzoxazoles, 2-Arylbenzimidazoles, and 1,3,5- Trisubstituted Pyrazoles, Synth. Commun., 36(15) , pages 2189 – 2194 (2006)
11.Ahmed S., Longchar M., Boruah R. C., Inverse electron demand diels-alder reaction : A facile synthetic route topyrazoles from conjugated oximes utilizing diimides as dipolarophile, Indian journal of chemistry. Sect. B: Org. Synth., 38(2), 125-127 (1999)
12.Jimenez-Cruz F., Hernandez-Ortega S., Ros-Olivares H., Synthesis and molcular structure of the novel monohydrated 3-p- nitrophenylpyrazole derived from 1,3-diketone malonate, J. Mol. Struct., 650, 223–231 (2003)
13.Suryakiran N., Srikanth Reddy T., Asha Latha K., Prabhakar P., Yadagiri K., Venkateswarlu Y., An expeditious synthesis of 3-amino 2H-pyrazoles promoted by methanesulphonic acid under solvent and solvent free conditions, J. Mol. Catal., 258, 371–375 (2006)
14.Faller A., Schuenke M., Thieme, The Human Body, 279-281 (2004)
15.Baumgartner H.P., Muggli R., Tschopp T.B. and Turitto V.T., Platelet adhension, release and aggregation in flowing blood : effects of surface properties and platelet function. Thromb. haemost., 35, 124-138 (1976)
16.Stemerman M.B., Baumgartner H.R. and Spaet T.H., The subendothelial microfibril and adhesion. Lab. Invest., 24, 176-186 (1972)
17.Malmsten C., Hamberg M., Svensson J., and Samuelsson B., Physiological role of and endoperoxide in human platelets:Hemostatic defect due to cyclooxygenase deficiency., Proc. Natl. Acad. Sci., 72, 1446-8 (1975)
18.Billes T., Smith J. B., and Silver M. J., Metabolism of 14C – arachidonic acid by human platelets., Biochem. Biophys. Acta, 241, 303-14 (1976)
19.Shepherd J. T. and Katusic Z. S., Endothelium derived vasoactive factors: Endothelium-dependent relaxation, Hypertension, 18 (Suppl.III): 76-85 (1991)
20.Huang E. M. and Detwiler W. D., Stimulus-response coupling mechanism, Orlande FL, Academic Press, Pl-68 (1986)
21.Waldman S. A., and Murad F., Cyclic GMP synthesis and function, Pharmacol Rev., 39, 163-96 (1987)
22.Coller B. S., Antiplatelet agents in the prevention and therapy of thrombosis. Annu. Rev. Med., 43, 171-80 (1992)
23.Shaun P. Jackson & Simone M. Schoenwaelder, Antiplatelet therapy: in search of the ''magic bullet''. Nat. Rev. Drug. Discov., 775-789 (2003)
24.Philip W. M., George J. B., Joseph P. M., and Douglas M. T.: Anticoagulant, Thrombolytic, and Antiplatelet Drugs. in Goodman and Gilman’s (eds): The Pharmacological Basis of Therapeutic. New York : Pergamon Press, Chap. 55, 1311-31 (1990)
|